Paul Erdman

744 citations

18 papers · 384 indexed · h-index 10

Organic Chemistry top 10%
Molecular Biology
Oncology
Cancer Research
Computational Theory and Mathematics top 10%

Co-authors: Moorthy S. S. Palanki Lynn J. Ransone Mark J. Suto Mark E. Goldman Philip B. Cox Anthony M. Manning Robert W. Sullivan Brydon L. Bennett
Topics: Cytokine Signaling Pathways and Interactions (6 papers)NF-κB Signaling Pathways (5 papers)Multiple Myeloma Research and Treatments (4 papers)
Cited by: Organic Chemistry Toxicology Cancer Research
Journals: Journal of Clinical Oncology Blood American Journal of Respiratory and Critical Care Medicine
Partner nations: United States Switzerland Japan

In The Last Decade

Paul Erdman

17 papers receiving 358 citations

Peers

Countries citing papers authored by Paul Erdman

Since Specialization

Citations

This map shows the geographic impact of Paul Erdman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Erdman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Erdman more than expected).

Fields of papers citing papers by Paul Erdman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Erdman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Erdman. The network helps show where Paul Erdman may publish in the future.

Co-authorship network of co-authors of Paul Erdman

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Erdman. A scholar is included among the top collaborators of Paul Erdman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Erdman. Paul Erdman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Discovery of a PDE4B and PDE4D selective bifunctional degrader for management of chronic inflammatory disorders 2025 ·Journal of Translational Autoimmunity ·Arvind Shakya,Qiao Liu,Chon Lai,(unknown),(unknown),Paul Erdman,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Yuan Yan Sin,George S. Baillie,Shenlin Huang,Aparajita H. Chourasia,(unknown)	0
2	BTX-1188, a first-in-class dual degrader of GSPT1 and IKZF1/3, for treatment of acute myeloid leukemia (AML) and solid tumors. 2022 ·Journal of Clinical Oncology ·Aparajita H. Chourasia,(unknown),(unknown),Paul Erdman,Ashwini Oke,David Hecht,(unknown),Frank Mercurio,Kyle Chan,Dung Thai,(unknown)	13
3	The novel protein homeostatic modulator BTX306 is active in myeloma and overcomes bortezomib and lenalidomide resistance 2020 ·Journal of Molecular Medicine ·(unknown),Richard J. Jones,Hua Wang,Isere Kuiatse,Fazal Shirazi,Elisabet E. Manasanch,Hans C. Lee,(unknown),(unknown),Normand Richard,Paul Erdman,(unknown),David Hecht,(unknown),(unknown),Aparajita H. Chourasia,Kyle Chan,Frank Mercurio,David Stirling,Robert Z. Orlowski	9
4	Discovery of SARxxxx92, a pan-PIM kinase inhibitor, efficacious in a KG1 tumor model 2020 ·Bioorganic & Medicinal Chemistry Letters ·Claude Barberis,Paul Erdman,(unknown),(unknown),(unknown),(unknown),(unknown),Joseph D. Batchelor,Jinyu Liu,Vinod F. Patel,Andrew Hebert,Mikhail Levit,Anlai Wang,Frank F. Sun,Shih-Min A. Huang	7
5	Abstract 1963: Targeting hematological malignancies with two functionally and mechanistically distinct classes of cereblon mediated protein homeostatic modulators 2020 ·Cancer Research ·Aparajita H. Chourasia,(unknown),(unknown),(unknown),(unknown),Normand Richard,(unknown),(unknown),Paul Erdman,(unknown),David Hecht,Kyle Chan,Frank Mercurio,David Stirling	2
6	Bioavailable Dual-Protein Degraders of CK1α and Transcriptional Kinase CDK9 As Potential Therapeutics for Hematological Malignancies 2019 ·Blood ·(unknown),Aparajita H. Chourasia,(unknown),(unknown),Paul Erdman,David Hecht,(unknown),(unknown),Normand Richard,Avanthika Venkatachalam,Irit Snir-Alkalay,Kyle Chan,Frank Mercurio,Yinon Ben‐Neriah,David Stirling	5
7	Design and Synthesis of Pyrrolidine-based Fragments That Sample Three-dimensional Molecular Space 2019 ·ACS Medicinal Chemistry Letters ·Philip Garner,Philip B. Cox,Upendra A. Rathnayake,(unknown),Paul Erdman	30
8	Discovery of N-substituted 7-azaindoles as Pan-PIM kinases inhibitors – Lead optimization – Part III 2018 ·Bioorganic & Medicinal Chemistry Letters ·Claude Barberis,(unknown),(unknown),(unknown),(unknown),(unknown),Paul Erdman,(unknown),John Jiang,(unknown),Vinod F. Patel,Andrew Hebert,Mikhail Levit,Anlai Wang,Frank F. Sun,Shih-Min A. Huang	7
9	Discovery of N-substituted 7-azaindoles as Pan-PIM kinase inhibitors – Lead series identification – Part II 2017 ·Bioorganic & Medicinal Chemistry Letters ·Claude Barberis,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Paul Erdman,Tahir Majid,Joseph D. Batchelor,Mikhail Levit,Andrew Hebert,(unknown),(unknown),Anlai Wang	5
10	Discovery of Antibacterial Biotin Carboxylase Inhibitors by Virtual Screening and Fragment-Based Approaches 2009 ·ACS Chemical Biology ·Igor Mochalkin,J. Richard Miller,Lakshmi Narasimhan,V. Thanabal,Paul Erdman,Philip B. Cox,J. V. N. Vara Prasad,Sandra Lightle,Michael D. Huband,C. Kendall Stover	75
11	Inhibition of Nuclear Factor-κB in T Cells Suppresses Lung Fibrosis 2007 ·American Journal of Respiratory and Critical Care Medicine ·Hajime Fujimoto,Corina N. D’Alessandro‐Gabazza,Moorthy S. S. Palanki,Paul Erdman,Takehiro Takagi,Esteban C. Gabazza,Nelson E. Bruno,Yutaka Yano,Tatsuya Hayashi,Shigenori Tamaki,Yasuhiro Sumida,Yukihiko Adachi,Koji Suzuki,Osamu Taguchi	21
12	Outdoor Vector Lab 2004 ·The Physics Teacher ·Paul Erdman	2
13	The design and synthesis of novel orally active inhibitors of AP-1 and NF-κB mediated transcriptional activation. SAR of In vitro and In vivo studies 2003 ·Bioorganic & Medicinal Chemistry Letters ·Moorthy S. S. Palanki,Paul Erdman,(unknown),Mark J. Suto,Brydon L. Bennett,Anthony M. Manning,Lynn J. Ransone,(unknown),Sonal J. Desai,(unknown),(unknown),Peter Tsao,Wataru Toriumi	32
14	Structure–Activity Relationship Studies of Ethyl 2-[(3-Methyl-2,5-dioxo(3-pyrrolinyl))amino]-4-(trifluoromethyl)pyrimidine-5-carboxylate: An Inhibitor of AP-1 and NF-κB Mediated Gene Expression 2002 ·Bioorganic & Medicinal Chemistry Letters ·Moorthy S. S. Palanki,(unknown),(unknown),Paul Erdman,(unknown),Mark E. Goldman,Lynn J. Ransone,(unknown)	36
15	Novel inhibitors of AP-1 and NF-κB mediated gene expression: structure–activity relationship studies of ethyl 4-[(3-Methyl-2,5-dioxo(3-pyrrolinyl))amino]-2-(trifluoromethyl)pyrimidine-5-carboxylate 2000 ·Bioorganic & Medicinal Chemistry Letters ·Moorthy S. S. Palanki,Paul Erdman,Anthony M. Manning,(unknown),Lynn J. Ransone,(unknown),Carla M. Suto,Mark J. Suto	29
16	Inhibitors of NF-κB and AP-1 Gene Expression: SAR Studies on the Pyrimidine Portion of 2-Chloro-4-trifluoromethylpyrimidine-5-[N-(3‘,5‘-bis(trifluoromethyl)phenyl)carboxamide] 2000 ·Journal of Medicinal Chemistry ·Moorthy S. S. Palanki,Paul Erdman,(unknown),(unknown),Robert W. Sullivan,Mark E. Goldman,Lynn J. Ransone,Brydon L. Bennett,Anthony M. Manning,Mark J. Suto	73
17	ChemInform Abstract: 2‐Chloro‐4‐(trifluoromethyl)pyrimidine‐5‐N‐(3′,5′‐bis (trifluoromethyl)phenyl)carboxamide: A Potent Inhibitor of NF‐ϰB‐ and AP‐1‐Mediated Gene Expression Identified Using Solution‐Phase Combinatorial Chemistry. 1998 ·ChemInform ·Robert W. Sullivan,(unknown),Paul Erdman,Moorthy S. S. Palanki,David W. Anderson,Mark E. Goldman,Lynn J. Ransone,Mark J. Suto	2
18	2-Chloro-4-(trifluoromethyl)pyrimidine-5-N-(3‘,5‘-bis(trifluoromethyl)phenyl)- carboxamide: A Potent Inhibitor of NF-κB- and AP-1-Mediated Gene Expression Identified Using Solution-Phase Combinatorial Chemistry 1998 ·Journal of Medicinal Chemistry ·Robert W. Sullivan,(unknown),Paul Erdman,Moorthy S. S. Palanki,David W. Anderson,Mark E. Goldman,Lynn J. Ransone,Mark J. Suto	36

About Paul Erdman

Paul Erdman is a scholar working on Hematology, Cancer Research and Oncology, having authored 18 papers that have together received 384 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (6 papers), NF-κB Signaling Pathways (5 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Organic Chemistry (186 citations), Toxicology (15 citations) and Cancer Research (61 citations). Paul Erdman has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Moorthy S. S. Palanki, Lynn J. Ransone, Mark J. Suto, Mark E. Goldman, Philip B. Cox, Anthony M. Manning, Robert W. Sullivan, Brydon L. Bennett, Igor Mochalkin and Lakshmi Narasimhan. Their work appears in journals such as Journal of Clinical Oncology, Blood and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact